The New, Blazing Fast HLA Twin v4.2

Two month ago, Omixon announced the release of the newest HLA Twin version which featured significant improvements in the software’s performance and responsiveness that facilitated the result review process and overall analysis workflow. Omixon team has been working on additional and even more significant improvements in HLA Twin. This time...

 

Read more

Webinar – HLA Typing Uses in Research. How is HLA Explore Used to Facilitate it?

Join us for a Webinar on Tuesday, April 7 with Efi Melista (Head of Product, Omixon) who will be talking about the uses of HLA typing in research and population studies, and how Omixon’s HLA Explore can facilitate it. Examples in disease associations, pharmacogenetics, drug sensitivities and overall population genetics...

 

Read more

Do You Know What it Takes to CE Mark an HLA Typing Product?

Abstract presentation by Omixon’s Senior Technical Lead Assay R&D, Dr. Gergely Tölgyesi, from the latest 14th East-West Immunogenetics Conference (Budapest, Hungary). Abstract: European transplantation laboratories require the use of CE-marked HLA typing products for diagnostic purposes. The CE mark (“Conformité Européenne”, French for European conformity) is a symbol that a...

 

Read more